Titre : Hépatite chronique

Hépatite chronique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer l'hépatite chronique ?

Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique.
Hépatite chronique Biopsie hépatique
#2

Quels tests sanguins sont utilisés ?

Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique.
Tests sanguins Enzymes hépatiques
#3

Qu'est-ce qu'une biopsie hépatique ?

C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions.
Biopsie hépatique Inflammation hépatique
#4

Quels sont les signes d'hépatite chronique ?

Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons.
Symptômes Jaunisse
#5

L'échographie est-elle utile ?

Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille.
Échographie Anomalies hépatiques

Symptômes 5

#1

Quels sont les symptômes courants ?

Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit.
Symptômes Fatigue
#2

La jaunisse est-elle un symptôme ?

Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux.
Jaunisse Peau
#3

Peut-on avoir des symptômes asymptomatiques ?

Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique.
Asymptomatique Hépatite chronique
#4

Les démangeaisons sont-elles fréquentes ?

Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang.
Démangeaisons Bile
#5

Y a-t-il des symptômes psychologiques ?

Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique.
Anxiété Dépression

Prévention 5

#1

Comment prévenir l'hépatite chronique ?

La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels.
Prévention Vaccination
#2

La vaccination est-elle efficace ?

Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections.
Vaccination Hépatite A
#3

Quels comportements à risque éviter ?

Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues.
Comportements à risque Drogues
#4

L'hygiène joue-t-elle un rôle ?

Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection.
Hygiène Infection
#5

Les tests de dépistage sont-ils importants ?

Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt.
Dépistage Hépatite chronique

Traitements 5

#1

Quels traitements existent pour l'hépatite chronique ?

Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien.
Antiviraux Immunomodulateurs
#2

Les antiviraux sont-ils efficaces ?

Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique.
Antiviraux Charge virale
#3

Quand faut-il envisager une transplantation ?

La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves.
Transplantation hépatique Insuffisance hépatique
#4

Y a-t-il des traitements naturels ?

Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin.
Traitements naturels Consultation médicale
#5

Comment surveiller l'évolution de la maladie ?

Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires.
Suivi médical Tests sanguins

Complications 5

#1

Quelles sont les complications possibles ?

Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique.
Cirrhose Cancer du foie
#2

La cirrhose est-elle réversible ?

Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie.
Cirrhose Évolution
#3

Quels signes indiquent une insuffisance hépatique ?

Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal.
Insuffisance hépatique Saignements
#4

Le cancer du foie est-il fréquent ?

Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique.
Cancer du foie Hépatite chronique
#5

Comment prévenir les complications ?

Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications.
Prévention Suivi médical

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes.
Facteurs de risque Alcoolisme
#2

L'usage de drogues augmente-t-il le risque ?

Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique.
Drogues injectables Hépatite chronique
#3

Les antécédents familiaux jouent-ils un rôle ?

Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie.
Antécédents familiaux Hépatite chronique
#4

Le sexe influence-t-il le risque ?

Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale.
Sexe Infection virale
#5

Les voyages à l'étranger sont-ils un risque ?

Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection.
Voyages Prévalence
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hépatite chronique : Questions médicales les plus fréquentes", "headline": "Hépatite chronique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hépatite chronique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-22", "dateModified": "2025-02-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hépatite chronique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie chronique", "url": "https://questionsmedicales.fr/mesh/D002908", "about": { "@type": "MedicalCondition", "name": "Maladie chronique", "code": { "@type": "MedicalCode", "code": "D002908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hépatite B chronique", "alternateName": "Hepatitis B, Chronic", "url": "https://questionsmedicales.fr/mesh/D019694", "about": { "@type": "MedicalCondition", "name": "Hépatite B chronique", "code": { "@type": "MedicalCode", "code": "D019694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.500" } } }, { "@type": "MedicalWebPage", "name": "Hépatite C chronique", "alternateName": "Hepatitis C, Chronic", "url": "https://questionsmedicales.fr/mesh/D019698", "about": { "@type": "MedicalCondition", "name": "Hépatite C chronique", "code": { "@type": "MedicalCode", "code": "D019698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.750" } } }, { "@type": "MedicalWebPage", "name": "Hépatite D chronique", "alternateName": "Hepatitis D, Chronic", "url": "https://questionsmedicales.fr/mesh/D019701", "about": { "@type": "MedicalCondition", "name": "Hépatite D chronique", "code": { "@type": "MedicalCode", "code": "D019701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.477.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Hépatite chronique", "alternateName": "Hepatitis, Chronic", "code": { "@type": "MedicalCode", "code": "D006521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Heiner Wedemeyer", "url": "https://questionsmedicales.fr/author/Heiner%20Wedemeyer", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany." } }, { "@type": "Person", "name": "Grace Lai-Hung Wong", "url": "https://questionsmedicales.fr/author/Grace%20Lai-Hung%20Wong", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Giuseppina Brancaccio", "url": "https://questionsmedicales.fr/author/Giuseppina%20Brancaccio", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy." } }, { "@type": "Person", "name": "Giovanni B Gaeta", "url": "https://questionsmedicales.fr/author/Giovanni%20B%20Gaeta", "affiliation": { "@type": "Organization", "name": "Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it." } }, { "@type": "Person", "name": "Maria Buti", "url": "https://questionsmedicales.fr/author/Maria%20Buti", "affiliation": { "@type": "Organization", "name": "Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study of infections caused by", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35967868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.867347" } }, { "@type": "ScholarlyArticle", "name": "Errors in Surgery: A Case Control Study.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35946794", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000005664" } }, { "@type": "ScholarlyArticle", "name": "Iron status in women with infertility and controls: a case-control study.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37361544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1173100" } }, { "@type": "ScholarlyArticle", "name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35788952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11695-022-06193-8" } }, { "@type": "ScholarlyArticle", "name": "Diverticulitis Familiality: A Statewide Case-Control Study.", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37403933", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XCS.0000000000000799" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Caractéristiques de la maladie", "item": "https://questionsmedicales.fr/mesh/D020969" }, { "@type": "ListItem", "position": 5, "name": "Maladie chronique", "item": "https://questionsmedicales.fr/mesh/D002908" }, { "@type": "ListItem", "position": 6, "name": "Hépatite chronique", "item": "https://questionsmedicales.fr/mesh/D006521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hépatite chronique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hépatite chronique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hépatite chronique", "description": "Comment diagnostiquer l'hépatite chronique ?\nQuels tests sanguins sont utilisés ?\nQu'est-ce qu'une biopsie hépatique ?\nQuels sont les signes d'hépatite chronique ?\nL'échographie est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hépatite chronique", "description": "Quels sont les symptômes courants ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des symptômes psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hépatite chronique", "description": "Comment prévenir l'hépatite chronique ?\nLa vaccination est-elle efficace ?\nQuels comportements à risque éviter ?\nL'hygiène joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hépatite chronique", "description": "Quels traitements existent pour l'hépatite chronique ?\nLes antiviraux sont-ils efficaces ?\nQuand faut-il envisager une transplantation ?\nY a-t-il des traitements naturels ?\nComment surveiller l'évolution de la maladie ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hépatite chronique", "description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nQuels signes indiquent une insuffisance hépatique ?\nLe cancer du foie est-il fréquent ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hépatite chronique", "description": "Quels sont les principaux facteurs de risque ?\nL'usage de drogues augmente-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes voyages à l'étranger sont-ils un risque ?", "url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Case-Control+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hépatite chronique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique." } }, { "@type": "Question", "name": "Qu'est-ce qu'une biopsie hépatique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions." } }, { "@type": "Question", "name": "Quels sont les signes d'hépatite chronique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons." } }, { "@type": "Question", "name": "L'échographie est-elle utile ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes asymptomatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir l'hépatite chronique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels." } }, { "@type": "Question", "name": "La vaccination est-elle efficace ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections." } }, { "@type": "Question", "name": "Quels comportements à risque éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues." } }, { "@type": "Question", "name": "L'hygiène joue-t-elle un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hépatite chronique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien." } }, { "@type": "Question", "name": "Les antiviraux sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique." } }, { "@type": "Question", "name": "Quand faut-il envisager une transplantation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin." } }, { "@type": "Question", "name": "Comment surveiller l'évolution de la maladie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique." } }, { "@type": "Question", "name": "La cirrhose est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie." } }, { "@type": "Question", "name": "Quels signes indiquent une insuffisance hépatique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal." } }, { "@type": "Question", "name": "Le cancer du foie est-il fréquent ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "L'usage de drogues augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale." } }, { "@type": "Question", "name": "Les voyages à l'étranger sont-ils un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 16/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Heiner Wedemeyer

3 publications dans cette catégorie

Affiliations :
  • Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany.
Publications dans "Hépatite chronique" :

Grace Lai-Hung Wong

3 publications dans cette catégorie

Affiliations :
  • Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.
Publications dans "Hépatite chronique" :

Giuseppina Brancaccio

2 publications dans cette catégorie

Affiliations :
  • Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy.
Publications dans "Hépatite chronique" :

Giovanni B Gaeta

2 publications dans cette catégorie

Affiliations :
  • Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it.
Publications dans "Hépatite chronique" :

Maria Buti

2 publications dans cette catégorie

Affiliations :
  • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatite chronique" :

Mar Riveiro-Barciela

2 publications dans cette catégorie

Affiliations :
  • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatite chronique" :

Rafael Esteban

2 publications dans cette catégorie

Affiliations :
  • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatite chronique" :

Theo Heller

2 publications dans cette catégorie

Affiliations :
  • Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Publications dans "Hépatite chronique" :

Karen J Campoverde Reyes

2 publications dans cette catégorie

Affiliations :
  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Publications dans "Hépatite chronique" :

Lung-Yi Mak

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Publications dans "Hépatite chronique" :

Wai-Kay Seto

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong.
  • Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Publications dans "Hépatite chronique" :

James Fung

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong.
Publications dans "Hépatite chronique" :

Man-Fung Yuen

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong.
Publications dans "Hépatite chronique" :

Peng Wang

2 publications dans cette catégorie

Affiliations :
  • Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • National Medical Center for Major Public Health Events, Wuhan, China.
  • State Key Laboratory for Zoonotic Diseases, Wuhan, China.

Qin Ning

2 publications dans cette catégorie

Affiliations :
  • Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • National Medical Center for Major Public Health Events, Wuhan, China.
  • State Key Laboratory for Zoonotic Diseases, Wuhan, China.

Hye Won Lee

2 publications dans cette catégorie

Affiliations :
  • Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Insitute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea; Liver Center, Severance Hospital, Seoul, South Korea.
Publications dans "Hépatite chronique" :

Terry Cheuk-Fung Yip

2 publications dans cette catégorie

Affiliations :
  • Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.
Publications dans "Hépatite chronique" :

Yee-Kit Tse

2 publications dans cette catégorie

Affiliations :
  • Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Publications dans "Hépatite chronique" :

Beom Kyung Kim

2 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Insitute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea; Liver Center, Severance Hospital, Seoul, South Korea.
Publications dans "Hépatite chronique" :

Seung Up Kim

2 publications dans cette catégorie

Affiliations :
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Insitute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea; Liver Center, Severance Hospital, Seoul, South Korea.
Publications dans "Hépatite chronique" :

Sources (10000 au total)

A case-control study of infections caused by

Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod... A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie... One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer... In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...

Errors in Surgery: A Case Control Study.

While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality.... Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events.... Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018... Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er... Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....

Iron status in women with infertility and controls: a case-control study.

Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown.... In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se... Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;... Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...

Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.

There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in... Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye... Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ... The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...

Diverticulitis Familiality: A Statewide Case-Control Study.

The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ... We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c... The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc... Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...

Thrombocytosis in patients with spondyloarthritis: a case-control study.

This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp... A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant... The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22... SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...

Vestibulodynia and the Vaginal Microbiome: A Case-Control Study.

Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r... This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls.... A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu... Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi... Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls... Additional studies are needed to further assess the clinical significance of these findings.... Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity.... Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...

Bladder cancer with pioglitazone: A case-control study.

Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes.... To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients.... In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa... A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde... Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...

HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case-control study and a prospective nested case-control study.

Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw... The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro... In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...